Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Assembly Biosciences Inc ASMB

Healthcare Biotechnology
Assembly Biosciences, Inc. is a biotechnology company, which is engaged in the development of small molecule antiviral therapeutics. The Company’s pipeline includes two helicase-primase inhibitors (HPI) targeting recurrent genital herpes, an orally bioavailable hepatitis delta virus (HDV) entry inhibitor, a clinical-stage capsid assembly modulator (CAM) designed to disrupt the replication cycle... see more

Recent & Breaking News (NDAQ:ASMB)

Ventrus Biosciences Files and Commences Mailing of Definitive Proxy Materials for July 10th Annual Meeting

GlobeNewswire June 9, 2014

Ventrus Biosciences to Merge With Assembly Pharmaceuticals

GlobeNewswire May 19, 2014

Ventrus Biosciences Receives Date for Type B Pre-NDA Meeting With FDA for DOLIZEM (Diltiazem Hydrochloride Cream) in Anal Fissures

GlobeNewswire April 4, 2014

Ventrus Biosciences Announces Results From Second Pivotal Phase 3 Trial of Diltiazem Cream (VEN 307) in Patients With Anal Fissure

GlobeNewswire February 12, 2014

Wall Street Fundamentals Releases New In-Depth Stock Reports on CGIX, RMTI, SCMP and VTUS

Accesswire September 30, 2013

InvestorsGuru.com 32 Filtered Mid-Day Market Movers Recap

Investors Guru September 14, 2013

Five Star Equities Issues New Research Reports on LVLT, RTIX, TTWO and VTUS

Accesswire September 12, 2013

Ventrus Biosciences Announces Positive Results From Clinical Dermal Safety and Pharmacokinetic Studies of Diltiazem (VEN 307)

Globe Newswire September 11, 2013

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Ventrus Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline -- VTUS

Globe Newswire July 7, 2013

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Ventrus Biosciences, Inc. to Contact the Firm

Globe Newswire July 3, 2013

VENTRUS BIOSCIENCES ALERT: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Ventrus Biosciences, Inc. of Class Action Lawsuit and the Deadline of July 8, 2013 to Seek a Lead Plaintiff Position

PR Newswire July 2, 2013

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Ventrus Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline -- VTUS

Globe Newswire June 28, 2013

VENTRUS BIOSCIENCES ALERT: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Ventrus Biosciences, Inc. of Class Action Lawsuit and the Deadline of July 8, 2013 to Seek a Lead Plaintiff Position

Business Wire June 18, 2013

Ventrus Biosciences, Inc. Investor Alert: Scott+Scott, Attorneys at Law, LLP Notifies Investors of Upcoming Deadline in Ventrus Class Action Lawsuit -- VTUS

Globe Newswire June 17, 2013

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Ventrus Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline -- VTUS

Globe Newswire June 14, 2013

VENTRUS BIOSCIENCES ALERT: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Ventrus Biosciences, Inc. of Class Action Lawsuit and the Deadline of July 8, 2013 to Seek a Lead Plaintiff Position

Marketwired June 5, 2013

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Ventrus Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline -- VTUS

Globe Newswire May 31, 2013

Shareholder Alert: Scott+Scott, Attorneys at Law, LLP Reminds Ventrus Biosciences, Inc. Investors of Upcoming Lead Plaintiff Deadline in Ventrus Class Action -- VTUS

Globe Newswire May 29, 2013

Scott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming Lead Plaintiff Deadline in Securities Class Action Against Ventrus Biosciences, Inc. -- VTUS

Globe Newswire May 24, 2013

Scott+Scott, Attorneys at Law, LLP Reminds Ventrus Biosciences, Inc. Investors of Upcoming Deadline in Securities Class Action Lawsuit -- VTUS

Globe Newswire May 22, 2013